市場調查報告書

生物醫藥品受託製造的全球市場:至2027年的分析與預測(各產品(生技藥品,生物相似藥),各類服務,各地區)

Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product (Biologics, Biosimilars), Service, and Geography

出版商 The Insight Partners 商品編碼 932083
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
生物醫藥品受託製造的全球市場:至2027年的分析與預測(各產品(生技藥品,生物相似藥),各類服務,各地區) Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product (Biologics, Biosimilars), Service, and Geography
出版日期: 2020年03月31日內容資訊: 英文 174 Pages
簡介

全球生物醫藥品受託製造市場預測將從2019年的137億2,713萬美元以年複合成長率8.2%擴大,到2027年達到254億9,726萬美元的規模。製藥公司的外包趨勢的擴大,生技藥品的需求擴大等帶動市場成長。可是,生物醫藥品受託製造業界的競爭加劇阻礙市場成長。

本報告提供全球生物醫藥品受託製造市場相關調查,市場概要和各市場區隔趨勢,各地區趨勢,及參與企業的簡介相關資訊彙整。

第1章 簡介

第2章 概要

第3章 調查方法

第4章 市場情況

  • 概要
  • PEST分析
  • 專家的見解

第5章 市場趨勢

  • 推動市場的要素
    • 製藥公司的外包擴大
    • 生技藥品需求的增加
  • 阻礙市場的要素
    • 產業內的競爭激烈
  • 市場機會
    • 新興市場
  • 未來趨勢
    • 醫藥品CMO產業的整合
  • 影響分析

第6章 全球市場分析

  • 市場收益預測
  • 各地區市場
  • 參與企業的市場定位

第7章 各產品市場分析

  • 概要
  • 各產品市場收益佔有率
  • 生技藥品
  • 生物相似藥

第8章 各類服務市場分析

  • 概要
  • 各類服務市場
  • 開發過程
  • 最後調劑業務
  • 分析與品管
  • 最後包裝

第9章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第10章 COVID-19大流行帶給全球生物醫藥品受託製造市場的影響

第11章 產業趨勢

  • 概要
  • 成長策略
  • 有機的發展
  • 無機的發展

第12章 企業簡介

第13章 附錄

目錄
Product Code: TIPRE00005512

The biopharmaceuticals contract manufacturing market was valued at US$ 13,727.13 million in 2019 and is expected to grow at a CAGR of 8.2% from 2020 to 2027 to reach US$ 25,497.26 million by 2027.

Driving factors of the biopharmaceuticals contract manufacturing market are increasing trend of outsourcing among pharmaceuticals companies and elevating demand for biologics. However, growing competition in biopharmaceutical contract manufacturing industry is hindering the growth of the market.

The contract manufacturing organization (CMO) offers numerous benefits, including reducing investments in facilities and drug development costs, to pharmaceutical companies, thereby improving net cash flow. Outsourcing is cheaper and increases the efficiency of manufacturing processes. Also, it allows pharmaceutical and biotechnology companies to redirect resources to other areas. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to pharmaceutical companies. Presently, many pharmaceuticals and biotechnology companies outsource various services from early-stage drug development to commercial-scale manufacturing. As the pharmaceuticals industry is shifting from large-scale production to more niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is leading to the rise in inclination toward CMOs.

The global biopharmaceuticals contract manufacturing market is segmented into product and services. The biopharmaceuticals contract manufacturing market, by product, is segmented into biologics and biosimilars. The biologics segment held the largest share of the market in 2019, whereas the biosimilar segment is anticipated to register the highest CAGR in the market during the forecast period. Based on services, the market is segmented into development process, final dosage operations, and final packaging. The development process held the largest share of the market in 2019, whereas analytical and quality control segment is estimated to register the highest CAGR in the market during the forecast period.

Some of the essential primary and secondary sources included in the report are The Pharma & Biopharma Outsourcing Association (PBOA), Centers for Disease Control and Prevention, and Organization for Economic Co-operation and Development.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biopharmaceuticals contract manufacturing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceuticals contract manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Biopharmaceutical Contract Manufacturing Market - By Product
    • 1.3.2 Global Biopharmaceutical Contract Manufacturing Market - By Service
    • 1.3.3 Global Biopharmaceutical Contract Manufacturing Market - By Geography

2. Biopharmaceutical Contract Manufacturing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Biopharmaceutical Contract Manufacturing - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Biopharmaceuticals Contract Manufacturing Market - Industry Dynamics

  • 5.1 Key Drivers
    • 5.1.1 Increasing Outsourcing by Pharmaceutical Companies
    • 5.1.2 Increasing Demand of Biologics
  • 5.2 Key Market Restraints
    • 5.2.1 Increasing Competition in the Industry
  • 5.3 Key Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Consolidation in Pharmaceutical CMO Industry
  • 5.5 Impact Analysis

6. Biopharmaceutical Contract Manufacturing Market - Global Analysis

  • 6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast And Analysis
  • 6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players
    • 6.3.1 Lonza Group AG
    • 6.3.2 Thermo Fisher Scientific, Inc.

7. Biopharmaceuticals Contract Manufacturing Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2019 and 2027)
  • 7.3 Biologics
    • 7.3.1 Overview
    • 7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.3 Monoclonal Antibodies
      • 7.3.3.1 Overview
      • 7.3.3.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.4 Recombinant Proteins
      • 7.3.4.1 Overview
      • 7.3.4.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.5 Vaccines
      • 7.3.5.1 Overview
      • 7.3.5.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.6 Others
      • 7.3.6.1 Overview
    • 7.3.7 Others: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Biosimilars
    • 7.4.1 Overview
    • 7.4.2 Biosimilars: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)

8. Biopharmaceuticals Contract Manufacturing Market - By Service

  • 8.1 Overview
  • 8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2019 and 2027 (%)
  • 8.3 Development Process
    • 8.3.1 Overview
    • 8.3.2 Development Process: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Final Dosage Operation
    • 8.4.1 Overview
    • 8.4.2 Final Dosage Operation: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Analytical and Quality Control
    • 8.5.1 Overview
    • 8.5.2 Analytical and Quality Control: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Final Packaging
    • 8.6.1 Overview
    • 8.6.2 Final Packaging: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)

9. Biopharmaceutical Contract Manufacturing Market - Geographic Analysis

  • 9.1 North America: Biopharmaceutical Contract Manufacturing Market
    • 9.1.1 Overview
    • 9.1.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 9.1.3.1 North America: Biologics Market, by Type, 2018-2027 (USD Million)
    • 9.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
    • 9.1.6 US: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 US: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.1.6.2.1 US: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.1.6.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.1.7 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.1.7.2.1 Canada: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.1.7.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.1.8 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.1.8.2.1 Mexico: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.1.8.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
  • 9.2 Europe: Biopharmaceutical Contract Manufacturing Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 9.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 9.2.3.1 Europe: Biologics Market, by Type, 2018-2027 (USD Million)
    • 9.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
    • 9.2.6 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.2.6.2.1 Germany: Biologics Market, by Type, 2018-2027 (USD Million)
    • 9.2.7 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.2.8 UK: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.1 UK: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.2.8.2.1 UK: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.2.8.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.2.9 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.1 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.2.9.2.1 France: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.2.9.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.2.10 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.1 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.2.10.2.1 Spain: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.2.10.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.2.11 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.1 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.2.11.2.1 Italy: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.2.11.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
  • 9.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 9.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 9.3.3.1 Asia Pacific: Biologics Market, by Type, 2018-2027 (USD Million)
    • 9.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
    • 9.3.6 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.1 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.3.6.2.1 China: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.3.6.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.3.7 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.1 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.3.7.2.1 Japan: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.3.7.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.3.8 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.1 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.3.8.2.1 India: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.3.8.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.3.9 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.1 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.3.9.2.1 South Korea: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.3.9.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.3.10 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.1 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.3.10.2.1 Australia: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.3.10.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
  • 9.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 9.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 9.4.3.1 Middle East & Africa: Biologics Market, by Type, 2018-2027 (USD Million)
    • 9.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country - 2019 & 2027, (%)
    • 9.4.6 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.4.6.2.1 Saudi Arabia: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.4.6.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.4.7 UAE: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 UAE: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.4.7.2.1 UAE: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.4.7.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.4.8 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
      • 9.4.8.1 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.4.8.2.1 South Africa: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.4.8.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
  • 9.5 South and Central America: Biopharmaceutical Contract Manufacturing Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
    • 9.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 9.5.3.1 South and Central America: Biologics Market, by Type, 2018-2027 (USD Million)
    • 9.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
    • 9.5.6 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.5.6.2.1 Brazil: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.5.6.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
    • 9.5.7 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.1 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 9.5.7.2.1 Argentina: Biologics Market, by Type, 2018-2027 (USD Million)
      • 9.5.7.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)

10. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market

  • 10.1 North America: Impact assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
  • 10.4 Rest of World: Impact Assessment of COVID-19 Pandemic

11. Biopharmaceutical Contract Manufacturing Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Boehringer Ingelheim International GmbH
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
  • 12.2 THERMO FISHER SCIENTIFIC INC.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 General Electric Company
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 MERCK KGAA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lonza
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Samsung Biologics.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 AbbVie Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 WUXI BIOLOGICS
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Ajinomoto Co. Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Inno Bio Ventures Sdn Bhd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Canada Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Mexico Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Europe Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Europe Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Germany Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Germany Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 19. UK Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 20. UK Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 21. UK Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 22. France Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 23. France Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 24. France Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Spain Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Italy Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 29. Italy Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Italy Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 32. Asia Pacific Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 34. China Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 35. China Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 36. China Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Japan Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 38. Japan Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Japan Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 40. India: R&D spending of Pharmaceutical companies (2010 & 2017)
  • Table 41. India Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 42. India Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 43. India Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Korea Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 45. South Korea Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 46. South Korea Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Australia Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 48. Australia Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Australia Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 51. Middle East & Africa Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 54. Saudi Arabia Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 56. UAE Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 57. UAE Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 58. UAE Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Africa Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Africa Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South Africa Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South and Central America Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 63. South and Central America Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 64. South and Central America Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Brazil Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 66. Brazil Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Brazil Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Argentina Biopharmaceutical Contract Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 69. Argentina Biologics Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Argentina Biopharmaceutical Contract Manufacturing Market, by Service - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Organic Developments Done By Companies
  • Table 72. Inorganic Developments Done By Companies
  • Table 73. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

LIST OF FIGURES

  • Figure 1. Biopharmaceutical Contract Manufacturing Market Segmentation
  • Figure 2. Biopharmaceutical Contract Manufacturing Segmentation, By Region
  • Figure 3. Global Biopharmaceutical Contract Manufacturing Market Overview
  • Figure 4. Biologics Segment Held Largest Share Of Product In Biopharmaceutical Contract Manufacturing Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Biopharmaceutical Contract Manufacturing Market, By Geography (US$ Million)
  • Figure 7. Global Biopharmaceutical Contract Manufacturing Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Biopharmaceutical Contract Manufacturing Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South And Central America PEST Analysis
  • Figure 14. Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints
  • Figure 15. Global Biopharmaceutical Contract Manufacturing Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Biopharmaceutical Contract Manufacturing Market - By Geography Forecast And Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Biopharmaceutical Contract Manufacturing Market
  • Figure 18. Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2019 and 2027)
  • Figure 19. Biologics: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Vaccines: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Others: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Biosimilars: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Biopharmaceuticals Contract Manufacturing Market, by Service, 2019 and 2027 (%)
  • Figure 26. Development Process: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Final Dosage Operation: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Analytical and Quality Control: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Final Packaging: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. North America: Biopharmaceutical Contract Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 31. North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 32. North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
  • Figure 33. US: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 34. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 35. Projection of the Use of Pharmaceutical Products in Mexico (Million Dollars)
  • Figure 36. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Europe: Biopharmaceutical Contract Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 38. Europe Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
  • Figure 40. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. UK: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. Asia Pacific Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
  • Figure 48. China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 54. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country - 2019 & 2027, (%)
  • Figure 56. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. UAE: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 58. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South and Central America: Biopharmaceutical Contract Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 60. South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
  • Figure 62. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. Impact of COVID-19 Pandemic In North America Country Markets
  • Figure 65. Impact of COVID-19 Pandemic In Europe Country Markets
  • Figure 66. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 67. Impact of COVID-19 Pandemic In Rest of World Country Markets
  • Figure 68. Growth Strategies Done by the Companies in the Market, (%)